QIAGEN, NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing;  QIAGEN Can Acquire All NeuMoDx Shares Not Currently Owned by QIAGEN for ~$234M